登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600713 证券简称：南京医药 编号：ls2026-015 债券代码：110098 债券简称：南药转债 南京医药集团股份有限公司 2024年度第一期中期票据 2026年付息公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 为保证南京医药集团股份有限公司（以下简称"公司"）2024年度第一期中期票据（债券简称：24南京医 药MTN001，债券代码：102480759.IB）付息工作的顺利进行，现将有关事宜公告如下： 一、本期债券基本情况 ■ 二、兑付相关事宜 托管在银行间市场清算所股份有限公司的债券，其付息资金由发行人在规定时间之前划付至银行间市场 清算所股份有限公司指定的收款账户后，由银行间市场清算所股份有限公司在付息日划付至债券持有人 指定的银行账户。债券付息日如遇法定节假日，则划付资金的时间相应顺延。债券持有人资金汇划路径 变更，应在付息前将新的资金汇划路径及时通知银行间市场清算所股份有限公司。因债券持有人资金汇 划路径变更未及时通知银行间市场清算所股份有限 ...

Core Viewpoint - Huaneng International's stock price remained stable at 7.03 CNY as of July 25, 2025, with a total market capitalization of 110.36 billion CNY, ranking 9th in the power sector and 139th in the A-share market [1]. Company Announcements - Huaneng International will hold a global investor conference call on July 30, 2025, to present its mid-year performance, featuring key executives including the chairman and independent directors [1]. - The company has completed the issuance of its first phase of corporate bonds for 2025, raising 2 billion CNY at an interest rate of 2.15%, with funds allocated for repaying bank loans and other debt obligations [1]. - Huaneng International has also issued its sixth phase of ultra-short-term financing bonds for 2025, amounting to 2 billion CNY with a maturity of 99 days and an interest rate of 1.43%, aimed at supplementing working capital and adjusting debt structure [2][3].

Core Viewpoint - The company, Wuchan Zhongda Group Co., Ltd., has announced the issuance of its sixth short-term financing bond for the year 2025, with a total planned issuance amount of 2 billion yuan and an issuance interest rate of 1.51% [1][2]. Group 1: Issuance Details - The company held its 16th board meeting on April 26, 2024, and the annual shareholders' meeting on May 21, 2024, where it approved the proposal to apply for the registration and issuance of debt financing instruments for the years 2024-2026 [1]. - The registration for the debt financing instruments has been accepted by the China Interbank Market Dealers Association, and the registration is valid for two years from the date of the notice [1]. - The company plans to issue various financial products, including short-term financing bonds, medium-term notes, perpetual notes, asset-backed notes, and green debt financing instruments during the registration period [1]. Group 2: Specifics of the Financing Bond - The sixth short-term financing bond (SCP006) has a term of 270 days, with an interest start date of July 18, 2025, and a repayment date of April 14, 2026 [2]. - The actual issuance amount matches the planned issuance amount of 2 billion yuan, with an issuance price of 100.00 yuan per 100 yuan face value [2]. - The lead underwriter for this issuance is China Everbright Bank Co., Ltd., with Industrial Bank Co., Ltd. serving as the co-lead underwriter [2].